COMPLICATIONS NEUROLOGIQUES
1.Darnell RB, Posner JB. Paraneoplastic syndromes involving the nervous system. N Engl J Med 2003; 349(16):1543-1554.
Excellente revue générale sur le sujet.
2. Buesa JM, Garcia-Teijido P, Losa R, Fra J. Treatment of ifosfamide encephalopathy with intravenous thiamin. Clin Cancer Res 2003; 9(12):4636-4637
Lettre rapportant une série de patients s'étant amélioré par injection iv de thiamine au cours d'une encéphalopathie à l'ifosfamide.
3. Itoh Y, Sendo T, Hirakawa T, Goromaru T, Takasaki S, Yahata H et al. Role of sensory nerve peptides rather than mast cell histamine in paclitaxel hypersensitivity. Am J Respir Crit Care Med 2004; 169(1):113-119.
Etude phusiopathologique faite chez le rat.
4. Kasper B, Harter C, Meissner J, Bellos F, Krasniqi F, Ho AD et al. Prophylactic treatment of known ifosfamide-induced encephalopathy for chemotherapy with high-dose ifosfamide? Support Care Cancer 2004; 12(3):205-207.
Cas clinique
5. Loblaw DA, Perry J, Chambers A, Laperriere NJ. Systematic review of the diagnosis and management of malignant extradural spinal cord compression: the Cancer Care Ontario Practice Guidelines Initiative's Neuro-Oncology Disease Site Group. J Clin Oncol 2005; 23(9):2028-2037.
Revue systématique
6. Chamberlain MC. Neoplastic meningitis. J Clin Oncol 2005; 23(15):3605-3613.
Revue narrative.
7. Lee JJ, Swain SM. Peripheral neuropathy induced by microtubule-stabilizing agents. J Clin Oncol 2006 Apr 1;24(10):1633-42.
Revue narrative.
8. Lachkar S, Bota S, Nouvet G, Thiberville L. Encéphalopathie aiguë après injection de paclitaxel. Rev Mal Respir 2006 Feb;23(1 Pt 1):73-7.
Cas clinique.
9. Richardson PG, Briemberg H, Jagannath S, Wen PY, Barlogie B, Berenson J, et al. Frequency, characteristics, and reversibility of peripheral neuropathy during treatment of advanced multiple myeloma with bortezomib. J Clin Oncol 2006 Jul 1;24(19):3113-20.
Etude clinique rétrospective basée sur deux essais.
10. Connolly RM, Doherty CP, Beddy P, O'Byrne K. Chemotherapy induced reversible posterior leukoencephalopathy syndrome. Lung Cancer 2007 Jun;56(3):459-63.
Cas clinique.
11. Wolf S, Barton D, Kottschade L, Grothey A, Loprinzi C. Chemotherapy-induced peripheral neuropathy: prevention and treatment strategies. Eur J Cancer 2008 Jul;44(11):1507-15.
Revue narrative.
12. Lee VH, Wijdicks EF, Manno EM, Rabinstein AA. Clinical spectrum of reversible posterior leukoencephalopathy syndrome. Arch Neurol 2008 Feb;65(2):205-10.
Etude rétrospective.
13. Legriel S, Marijon H, Darmon M, Lemiale V, Bedos JP, Schlemmer B, et al. Central neurological complications in critically ill patients with malignancies. Intensive Care Med 2010 Feb;36(2):232-40.
Etude rétrospective.
14. Braik T, Evans AT, Telfer M, McDunn S. Paraneoplastic neurological syndromes: unusual presentations of cancer. A practical review. Am J Med Sci 2010 Oct;340(4):301-8.
Revue narrative.
15. Legriel S, Azoulay E. Complications neurologiques des traitements anticancéreux. Réanimation 2012;21:613-24.
Revue narrative.